Inhibition of oxidative stress and improvement of endothelial function by amlodipine in angiotensin II-infused rats.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  American Journal of Hypertension

• Publication date

  2004-02-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/J.AMJHYPER.2003.09.007PMID 14751660
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence for enhanced 8‐isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease

  2003cited by this paper
• Expression of a Functionally Active gp91phox-Containing Neutrophil-Type NAD(P)H Oxidase in Smooth Muscle Cells From Human Resistance Arteries: Regulation by Angiotensin II

  2002cited by this paper
• Mitochondrial Reactive Oxygen Species Trigger Calcium Increases During Hypoxia in Pulmonary Arterial Myocytes

  2002cited by this paper
• Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients.

  2002cited by this paper
• The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis.

  2002cited by this paper
• Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications.

  2002cited by this paper
• Critical Role of NADPH Oxidase-derived Reactive Oxygen Species in Generating Ca2+ Oscillations in Human Aortic Endothelial Cells Stimulated by Histamine*

  2002cited by this paper
• Mechanisms of plaque stabilization for the dihydropyridine calcium channel blocker amlodipine: review of the evidence.

  2002cited by this paper
• Endothelial function and oxidative stress in renovascular hypertension.

  2002cited by this paper
• LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis.

  2002cited by this paper
• Role of Endothelin and Isoprostanes in Slow Pressor Responses to Angiotensin II

  2001cited by this paper
• Interactions Between Nitric Oxide and Lipid Oxidation Pathways: Implications for Vascular Disease

  2001cited by this paper
• The Binding of Oxidized Low Density Lipoprotein (ox-LDL) to ox-LDL Receptor-1 Reduces the Intracellular Concentration of Nitric Oxide in Endothelial Cells through an Increased Production of Superoxide*

  2001cited by this paper
• Oxidative Stress in Arterial Hypertension: Role of NAD(P)H Oxidase

  2001cited by this paper
• Role of NAD(P)H Oxidase

  2001cited by this paper
• Redox-sensitive regulation of lox-1 gene expression in vascular endothelium.

  2001cited by this paper
• 8-iso-Prostaglandin F2&agr; Increases Expression of LOX-1 in JAR Cells

  2001cited by this paper
• Angiotensin II induced cardiac hypertrophy in vivo is inhibited by cyclosporin A in adult rats.

  2001cited by this paper
• 8-iso-prostaglandin F(2alpha) increases expression of LOX-1 in JAR cells.

  2001cited by this paper
• Effect of Amlodipine on the Progression of Atherosclerosis and the Occurrence of Clinical Events

  2000cited by this paper
• Modeling the interaction of peroxynitrite with low-density lipoproteins. II: reaction/diffusion model of peroxynitrite in low-density lipoprotein particles.

  2000cited by this paper
• Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein.

  1999cited by this paper
• The cardiovascular effects and implications of peroxynitrite.

  1999cited by this paper
• Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine.

  1999cited by this paper
• Angiotensin II induces superoxide anion production by mesangial cells.

  1998cited by this paper
• Effects of enalapril and amlodipine on small‐artery structure and composition, and on endothelial dysfunction in spontaneously hypertensive rats

  1998cited by this paper
• Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension.

  1997influential reference
• Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine.

  1997cited by this paper
• The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension.

  1997cited by this paper
• Endothelium-dependent relaxation in resistance arteries from spontaneously hypertensive rats: effect of long-term treatment with perindopril, quinapril, hydralazine or amlodipine

  1996cited by this paper
• Role of calcium in angiotensin II-induced prostaglandin release and DNA synthesis in rat vascular smooth muscle cells.

  1996cited by this paper
• Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.

  1996cited by this paper
• Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite.

  1995cited by this paper
• Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.

  1994cited by this paper

• Application of Flow-Mediated Dilation in Metabolic Syndrome

  2025cites this paper
• Effects of calcium channel blockers on perioperative ischemic events in hypertensive patients with intracranial aneurysms undergoing neurointervention

  2024cites this paper
• The Relationship Between Oxidative Stress and Infertility Due to Antihypertensive Drugs in Rattus Norvegicus

  2024cites this paper
• Oxidative Stress in Kidney Injury and Hypertension

  2024cites this paper
• The Framingham Study on Cardiovascular Disease Risk and Stress-Defenses: A Historical Review

  2023cites this paper
• Protein tyrosine nitration in atherosclerotic endothelial dysfunction.

  2022cites this paper
• Reactive Oxygen Species Scavenging Nanomedicine for the Treatment of Ischemic Heart Disease

  2022cites this paper
• Hypoxia and chronic kidney disease: Possible mechanisms, therapeutic targets, and relevance to cats.

  2021cites this paper
• LDL-Cholesterol and Platelets: Insights into Their Interactions in Atherosclerosis

  2021cites this paper
• Involvement of Angiotensin II Type 1 Receptor and Calcium Channel in Vascular Remodeling and Endothelial Dysfunction in Rats with Pressure Overload

  2020cites this paper
• Effect of Amlodipine and l-Carnitin Separately and Collectively on Certain Body Parameters that Are Related to Bone Metabolism in Ovariectomized Albino Rats

  2020cites this paper
• Lipid Peroxidation in Atherosclerotic Cardiovascular Diseases

  2020cites this paper
• Endothelin-1-Induced Microvascular ROS and Contractility in Angiotensin-II-Infused Mice Depend on COX and TP Receptors

  2019cites this paper
• ANTIHYPERTENSION STUDY OF ANREDERA CORDIFOLIA (TEN). V. STEENIS EXTRACT AND ITS FRACTIONS IN RATS THROUGH DEXAMETHASONE INDUCTION AND NITRIC OXIDE RELEASE.

  2018cites this paper
• Puerarin protects against endothelial dysfunction and end-organ damage in Ang II-induced hypertension

  2017cites this paper
• Contribution of lectin-like oxidized low-density lipoprotein receptor-1 and LOX-1 modulating compounds to vascular diseases.

  2017cites this paper
• Association Between the Angiotensinogen Gene Polymorphism and The

  2016cites this paper
• Association Between the Angiotensinogen Gene Polymorphism and The

  2016cites this paper
• Effects of Administration of Amlodipine and Lacidipine on Inflammation-Induced Bone Loss in the Ovariectomized Rat

  2016cites this paper
• Effect of Angiotensin Receptor Blokers (ARBs) and Calcium Channel Blockers (CCBs) In Rat Cerebral Ischemia Reperfusion I/R Injury.

  2015cites this paper
• Transcription Factor Avian Erythroblastosis Virus E26 Oncogen Homolog-1 Is a Novel Mediator of Renal Injury in Salt-Sensitive Hypertension

  2015cites this paper
• Docosahexaenoic acid decreases TNF-α-induced lectin-like oxidized low-density lipoprotein receptor-1 expression in THP-1 cells.

  2014cites this paper
• Combination therapy of amlodipine and atorvastatin has more beneficial vascular effects than monotherapy in salt-sensitive hypertension.

  2014cites this paper
• Modulation of adiponectin as a potential therapeutic strategy.

  2014cites this paper
• Amlodipine prevents apoptotic cell death by correction of elevated intracellular calcium in a primary neuronal model of Batten disease (CLN3 disease).

  2013cites this paper
• Cuminum cyminum, a Dietary Spice, Attenuates Hypertension via Endothelial Nitric Oxide Synthase and NO Pathway in Renovascular Hypertensive Rats

  2013cites this paper
• Oxidative stress contributes to sex differences in angiotensin II-mediated hypertension in spontaneously hypertensive rats.

  2012cites this paper
• Adiponectin and cardiovascular disease: mechanisms and new therapeutic approaches.

  2012cites this paper
• LOX-1 in atherosclerosis: biological functions and pharmacological modifiers

  2012cites this paper
• Ox‐LDL‐induced LOX‐1 expression in vascular smooth muscle cells: role of reactive oxygen species

  2011cites this paper
• Amlodipine ameliorates endothelial dysfunction in mesenteric arteries from spontaneously hypertensive rats

  2011cites this paper
• Additive beneficial effects of atorvastatin combined with amlodipine in patients with mild-to-moderate hypertension.

  2011cites this paper
• Current pharmacotherapeutic concepts for the treatment of cardiovascular disease in diabetics

  2010cites this paper
• Vascular Endothelial Function and Hypertension: Insights and Directions

  2010cites this paper
• Inflammation and Therapy for Hypertension

  2010cites this paper
• Improving vascular function in hypertension: potential benefits of combination therapy with amlodipine and renin–angiotensin–aldosterone system blockers

  2010cites this paper
• Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs.

  2010cites this paper
• Amlodipine improves endothelial function and metabolic parameters in patients with hypertension.

  2009cites this paper
• Antiatherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies.

  2009cites this paper
• Effet de l'atorvastatine et de l'amlodipine sur le remodelage vasculaire dans l'hypertension

  2009cites this paper
• Nitric oxide dysfunction in vascular endothelium and platelets: role in essential hypertension

  2009cites this paper
• Effect of CV159-Ca(2+)/calmodulin blockade on redox status hepatic ischemia-reperfusion injury in mice evaluated by a newly developed in vivo EPR imaging technique.

  2008cites this paper
• Modulation of arterial reactivity using amlodipine and atorvastatin measured by ultrasound examination (MARGAUX).

  2008cites this paper
• Does reversal of oxidative stress and inflammation provide vascular protection?

  2008cites this paper
• Misinterpretation of the effect of amlodipine on cytosolic calcium concentration with fura-2 fluorospectrometry

  2008cites this paper
• The renin-angiotensin system and therapeutic vaccines for hypertension.

  2008cites this paper
• Effec to fCV159-Ca 2 /Calmoduli nBlockad eo nRedo xStatu sHepatic Ischemia-Reperfusio nInjur yi nMic eEvaluate db ya Newl yDeveloped I nViv oEP RImagin gTechnique

  2008cites this paper
• Comparison of vasculoprotective effects of benidipine and losartan in a rat model of metabolic syndrome.

  2008cites this paper
• Oral direct renin inhibition: premise, promise, and potential limitations of a new antihypertensive drug.

  2008cites this paper
• Protective Effects of Lithospermic Acid B on Diabetic Nephropathy in OLETF Rats Comparing with Amlodipine and Losartan

  2008cites this paper
• Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability.

  2008cites this paper
• Treatment with amlodipine and atorvastatin has additive effect on blood and plaque inflammation in hypertensive patients with carotid atherosclerosis.

  2008cites this paper
• Pathophysiology of Target‐Organ Disease: Does Angiotensin II Remain the Key?

  2007cites this paper
• Diabetic vasculopathy and the lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1).

  2007cites this paper
• Renal and vascular protective effects of cilnidipine in patients with essential hypertension

  2007cites this paper
• Angiotensin II stimulates the reactivity of the pituitary-adrenal axis in leptin-resistant Zucker rats, thereby influencing the glucose utilization.

  2007cites this paper
• Renal dysfunction in hypertension and obesity

  2007cites this paper
• Calcium Channel Blockers Reduce Angiotensin II-Induced Superoxide Generation and Inhibit Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Expression in Endothelial Cells

  2006cites this paper
• Amlodipine-Induced Reduction of Oxidative Stress in the Brain Is Associated with Sympatho-Inhibitory Effects in Stroke-Prone Spontaneously Hypertensive Rats

  2006cites this paper
• Calcium [corrected] channel blockers reduce angiotensin II-induced superoxide generation and inhibit lectin-like oxidized low-density lipoprotein receptor-1 expression in endothelial cells.

  2006cites this paper
• Reduced NAD(P)H Oxidase in Low Renin Hypertension: Link Among Angiotensin II, Atherogenesis, and Blood Pressure

  2006cites this paper
• Role of adrenal gland hormones in antiinflammatory effect of calcium channel blockers.

  2006cites this paper
• Vascular protection of dual therapy (atorvastatin-amlodipine) in hypertensive patients.

  2006cites this paper
• ROLE OF MECHANICAL VERSUS HUMORAL EFFECTS OF ANGIOTENSIN II ON VASCULAR REMODELING

  2006cites this paper
• Beneficial Effects of Combined Benazepril-Amlodipine on Cardiac Nitric Oxide, cGMP, and TNF-α Production After Cardiac Ischemia

  2006cites this paper
• Ghrelin inhibits vascular superoxide production in spontaneously hypertensive rats.

  2006cites this paper
• Angiotensin‐Converting Enzyme Inhibition Reduces Lipid Deposits in Myocardium and Improves Left Ventricular Function of Obese Zucker Rats

  2006cites this paper
• Nitric Oxide in Hypertension

  2006cites this paper
• Benazepril Combined with Either Amlodipine or Hydrochlorothiazide Is More Effective than Monotherapy for Blood Pressure Control and Prevention of End-organ Injury in Hypertensive Dahl Rats

  2006cites this paper
• A Randomized, Double‐Blind Trial Comparing the Effects of Amlodipine Besylate/Benazepril HCl vs Amlodipine on Endothelial Function and Blood Pressure

  2006cites this paper
• Effect of Barnidipine on Blood Pressure and Serum Metabolic Parameters in Patients With Essential Hypertension: A Pilot Study

  2006cites this paper
• Renal and vascular hypertension-induced inflammation: role of angiotensin II

  2006cites this paper
• Correlation of flow mediated dilation with inflammatory markers in patients with impaired cardiac function. Beneficial effects of inhibition of ACE

  2006cites this paper
• ROLE OF MECHANICAL VERSUS HUMORAL EFFECTS OF ANGIOTENSIN II ON VASCULAR REMODELING

  2006cites this paper
• Nitric oxide, angiotensin II, and reactive oxygen species in hypertension and atherogenesis

  2005cites this paper
• Heme oxygenase-1 in vascular smooth muscle cells counteracts cardiovascular damage induced by angiotensin II.

  2005cites this paper
• Current and Future Novel Targets of Gene Therapy for Hypertension

  2005cites this paper
• Endothelial dysfunction: its role in hypertensive coronary disease

  2005cites this paper
• HOMOCYSTEINE AND HYPERTENSION : Associations between homocysteine and essential hypertension in treated and untreated hypertensive patients with and without coronary artery disease

  2005cites this paper
• The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease.

  2005cites this paper
• Angiotensin II and vascular inflammation.

  2005cites this paper
• Metabolic syndrome and endothelial dysfunction

  2005cites this paper
• Vascular but not cardiac remodeling is associated with superoxide production in angiotensin II hypertension

  2005cites this paper
• Angiotensin‐converting enzyme 2 as a novel target for gene therapy for hypertension

  2005cites this paper
• An in vitro study of the peroxyl and hydroxyl radical scavenging capacity of the calcium antagonist amlodipine.

  2004cites this paper
• Atorvastatin Prevents End-Organ Injury in Salt-Sensitive Hypertension: Role of eNOS and Oxidant Stress

  2004cites this paper